Congresses as Topic/organization & administration; HIV Infections/drug therapy; HIV-1/pathogenicity; Societies, Scientific/organization & administration; Adenine/analogs & derivatives; Adenine/therapeutic use; Antiretroviral Therapy, Highly Active/methods; Chemistry, Pharmaceutical/trends; Clinical Trials as Topic; Darunavir; Drugs, Investigational/therapeutic use; Enfuvirtide; HIV Envelope Protein gp41/therapeutic use; HIV Infections/mortality; HIV Infections/prevention & control; HIV-1/drug effects; Humans; Nitriles/chemistry; Nitriles/therapeutic use; Organophosphonates/therapeutic use; Peptide Fragments/therapeutic use; Pyrimidines/chemistry; Pyrimidines/therapeutic use; Receptors, CCR5/drug effects; Reverse Transcriptase Inhibitors/chemistry; Reverse Transcriptase Inhibitors/therapeutic use; Rilpivirine; Sulfonamides/chemistry; Sulfonamides/therapeutic use; Tenofovir; Zalcitabine/analogs & derivatives; Zalcitabine/chemistry; Zalcitabine/therapeutic use